Patent Landscape and IP Strategy for Biotech Diligence
Map biotech patent families, assignees, citations, jurisdictions, claims, and whitespace using EPO, Google Patents data, web extraction, and structured IP workflows.
Decision questions
What this solution is built to answer.
Who controls the relevant patent families and jurisdictions?
Where are the claim, citation, assignee, or FTO risk signals?
What filings affect competitive timing or market entry?
Which patent clusters suggest whitespace or crowding?
Capabilities
What ARiDA can run for this use case.
EPO and Google Patents search paths.
Assignee and inventor portfolio analysis.
Citation mapping and jurisdiction-level evidence.
Patent full-text extraction and fallback web acquisition.
Patent-cliff visuals for competitive deep dives.
Workflow table
Named workflows and expected artifacts.
| Workflow | Role | Artifacts |
|---|---|---|
| patent-landscape-analysis | IP landscape and whitespace analysis | Patent findings, assignee tables, citation maps, jurisdiction notes |
| competitive-landscape-deepdive | Patent timing inside competitive strategy | Patent cliff, TPP radar, competitive landscape report |
Evidence inputs
Data sources, tools, and user context.
Outputs
What the workflow should leave behind.
Deliverables
Patent landscape report with assignees, families, citations, and jurisdictions.
Patent-cliff timing visual.
IP risk and whitespace notes for diligence.
Structured input for competitive or BD analysis.
Proof points
The patent specialist has both EPO and Google Patents data paths.
Patent evidence can run as an independent lane in competitive deep dives.
Firecrawl remains available for pages that require heavier extraction.
FAQ
Common evaluation questions.
Is this a legal opinion?
ARiDA can structure patent evidence and diligence materials, while legal conclusions and FTO opinions still require qualified counsel.
Can patent findings connect to valuation?
Yes. Patent timing, exclusivity, and competitive pressure can feed loss-of-exclusivity assumptions, scenarios, and portfolio risk narratives.
Related solutions
Competitive Intelligence
Build competitive landscapes, TPP comparisons, patent-cliff views, market-share scenarios, and response plans from live web, trial, patent, literature, and database evidence.
Biotech Valuation
ARiDA runs evidence-backed biotech valuation workflows across single assets, multi-asset portfolios, platforms, fundraises, real options, Monte Carlo risk, and board dossiers.
Indication Expansion
Scan, assess, and sequence indication opportunities with scientific rationale, clinical feasibility, competitive density, IP context, market structure, and valuation logic.
Related reading
How to Run a Competitive Landscape Deep Dive in One Workspace
A useful competitive landscape changes posture. Collection alone leaves the hard judgment unfinished.
The End of Fragmented Biotech Research Workflows
The biggest tax in biotech research is no longer access to information. It is moving half-processed information across too many disconnected systems.
How Auditability Works: Files, Artifacts, Citations, and Workflow State
Auditability comes from preserving enough work structure that another professional can inspect what happened and continue from it.